[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @CACancerJournal CA: A Cancer Journal for Clinicians CA: A Cancer Journal for Clinicians posts on X about hbot the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::19082552/interactions)  - X Week XXXXX +10% - X Month XXXXX +674% - X Months XXXXXX +108% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::19082552/posts_active)  ### Followers: XXXXXX [#](/creator/twitter::19082552/followers)  - X Week XXXXXX +0.14% - X Month XXXXXX +0.53% - X Months XXXXXX +4.70% - X Year XXXXXX +5.70% ### CreatorRank: undefined [#](/creator/twitter::19082552/influencer_rank)  ### Social Influence **Social topic influence** [hbot](/topic/hbot) ### Top Social Posts Top posts by engagements in the last XX hours "In this new review @CasDejonckheere et al summarize mechanisms and evidence on Hyperbaric Oxygen Therapy (HBOT) for radiotherapy-related late effects by evaluating randomized trials cohort studies and realworld data. #OpenAccess 🔗: @OncoAlert" [X Link](https://x.com/CACancerJournal/status/2000569996523532619) 2025-12-15T14:13Z 10.5K followers, 1387 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@CACancerJournal CA: A Cancer Journal for CliniciansCA: A Cancer Journal for Clinicians posts on X about hbot the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social topic influence hbot
Top posts by engagements in the last XX hours
"In this new review @CasDejonckheere et al summarize mechanisms and evidence on Hyperbaric Oxygen Therapy (HBOT) for radiotherapy-related late effects by evaluating randomized trials cohort studies and realworld data. #OpenAccess 🔗: @OncoAlert"
X Link 2025-12-15T14:13Z 10.5K followers, 1387 engagements
/creator/x::CACancerJournal